Saturday, June 19, 2021 11:44:48 AM
Finally had time to look Hanuman. This is from their June corporate slides.
• July 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 9 months of open-label treatment with simufilam.
• New dataset will be presented July 29th at the 2021 Alzheimer’s Association International
Conference (AAIC) in Denver.
• AAIC’s scientific committee has invited the Company’s scientists to present the dataset as an
oral presentation.
• Sept 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 12 months of open-label treatment with simufilam.
• July 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 9 months of open-label treatment with simufilam.
• New dataset will be presented July 29th at the 2021 Alzheimer’s Association International
Conference (AAIC) in Denver.
• AAIC’s scientific committee has invited the Company’s scientists to present the dataset as an
oral presentation.
• Sept 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 12 months of open-label treatment with simufilam.
Recent FLNA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 09:16:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:10:21 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:06:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:04:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:01:27 PM
